Friday, 28 September 2018

Durvalumab May Improve Survival of Non-small Cell Lung Cancer Patients

Non-small cell lung cancer patients have improved survival rate with durvalumab along with platinum-based chemoradiotherapy.


from Medindia Health News https://ift.tt/2NK7Csa

No comments:

Post a Comment